ID: ALA5207545

Max Phase: Preclinical

Molecular Formula: C20H18N2O3

Molecular Weight: 334.38

Associated Items:

Representations

Canonical SMILES:  O=c1ccc2cc(OCCCCn3cnc4ccccc43)ccc2o1

Standard InChI:  InChI=1S/C20H18N2O3/c23-20-10-7-15-13-16(8-9-19(15)25-20)24-12-4-3-11-22-14-21-17-5-1-2-6-18(17)22/h1-2,5-10,13-14H,3-4,11-12H2

Standard InChI Key:  ZNODOKXMXCWWEQ-UHFFFAOYSA-N

Associated Targets(non-human)

Sprivivirus cyprinus 5 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 334.38Molecular Weight (Monoisotopic): 334.1317AlogP: 4.00#Rotatable Bonds: 6
Polar Surface Area: 57.26Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.37CX LogP: 3.51CX LogD: 3.51
Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.39Np Likeness Score: -0.95

References

1. G AC, Gondru R, Li Y, Banothu J..  (2022)  Coumarin-benzimidazole hybrids: A review of developments in medicinal chemistry.,  227  [PMID:34715585] [10.1016/j.ejmech.2021.113921]

Source